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doi:10.1016/j.jmii.2010.02.002Background: Serratia marcescens is a well-known but relatively uncommon cause of nosoco-
mial infections, particularly in neonatal intensive care unit (NICU) patients. We investigated
an outbreak of S marcescens in the NICU at the Farabi Hospital of Karadeniz Technical Univer-
sity in Trabzon, Turkey.
Methods: Between March 21 and May 27, 2006, nine of the neonates were identified with
cultures of S marcescens, and there were three deaths because of septicemia. For the purpose
of identifying the source of infection, 85 environmental samples, two breast milk samples from
two babies’ mothers, and 38 hand-washing samples from the health care workers (HCWs) were
collected for the detection of S marcescens. All the S marcescens isolates were genotyped by
pulsed-field gel electrophoresis with endonuclease SpeI restriction enzyme.
Results: Serratia marcescens was identified from one hand-washing sample and two breast
milk samples. None of the environmental samples yielded S marcescens. Of the 13 isolates
analyzed, four belonged to one major genotype, whereas eight (6 from neonates and 2 from
breast milk) were indistinguishable; two isolates (2 from neonates) were closely related;
and three isolates (2 other neonates and 1 from HCW’s hand) were different. Our intensive
efforts failed to determine the source of the outbreak despite the finding that S marcescens
strain was isolated from a HCW’s hand.
Conclusion: Present investigation suggested that an outbreak of S marcescens infection was
caused by a major clone in our NICU, possibly transmitted through the hands of HCWs,t of Clinical Microbiology, Karadeniz Technical University, Faculty of Medicine, Kalkınma Campus,
ail.com, gulcinb@ktu.edu.tr (G. Bayramoglu).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
112 G. Bayramoglu et al.emphasizing that strict hand washing before and after contact with patients must be the rule
of the thumb.
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Serratia is a genus of gram-negative rod belonging to the
Enterobacteriaceae family. Serratia marcescens is the
species of Serratia most commonly isolated from human
infections.1 Serratia marcescens, although initially thought
to be nonpathogenic and relatively uncommon in the
health care system, appears to emerge as a cause of
serious nosocomial infections, especially in neonatal
intensive care units (NICUs).2,3 Urinary tract infections are
not uncommon, followed by pneumonias and skin and soft
tissue infections.1
Management of S marcescens-associated infection is
problematic becausemany strains of the bacteriummanifest
resistance to multiple antibiotics, including b-lactams,
aminoglycosides, and quinolones.1,4 Therefore, it is impor-
tant to identify the sources of the outbreak for better
management of the spread of the organism. In our NICU, an
increase in the number of cases of S marcescens was
observed over the past few months, and thus, an epidemio-
logic investigation was launched on the clinical features of




The study was carried out in a 720-bed, tertiary care,
teaching hospital of Farabi in Trabzon, Turkey. The NICU
has 20 beds admitting critically ill neonates. The unit ad-
mits between 500 and 600 patients annually. Three sinks
with sensor-operated automatic faucets are available in the
NICU, and gloves are used routinely. Hand disinfectants
containing alcohol are kept near each bed. Active sur-
veillance for nosocomial infections are performed by the
infection control nurses and infectious-disease specialists,
using the criteria proposed by the Centers for Disease
Control and Prevention and National Nosocomial Infections
Surveillance System methodology.
Between March 21 and May 27, 2006, an increase in the
number of cases of S marcescens infection was observed
in the NICU; nine neonates became infected and one was
identified to be colonized with S marcescens, three of
whom died with septicemia (Table 1). Seven of these neo-
nates were born prematurely.
The study was initiated when a female infant was found to
have S marcescens sepsis and died on March 23, 2006. She
(gestational week 40) was delivered vaginally in another
hospital in Trabzon. The 5-day-old neonatewas transferred to
our NICU because of neonatal convulsion and generalized
hypotonia for further management. On the 7th day of admis-
sion, S marcescens was grown in a blood culture. Within
a week, microbiological samples yielded S marcescens fromtwo more neonates in the NICU. The neonates infected with
S marcescens were treated with antibiotic regimens, inclu-
ding meropenem (60 mg/kg per day divided into 3 doses) and
amikacin (15 mg/kg per day divided into 2 doses).
Bacterial isolates
Serratia marcescens was isolated from clinical speci-
mens using routine bacteriological procedures. All clinical
samples except blood were inoculated onto trypticase soy
agar with 5% sheep’s blood (Becton Dickinson Bioscience,
Sparks, MD, USA) and eosin methylene blue agar (Hi - Media
Laboratories, Mumbai, India) plates, whereas the blood
samples were inoculated first into an aerobic BACTEC 9240
Peds Plus bottle (Becton Dickinson Bioscience). Specimens
for surveillance cultures from hospitalized neonates were
obtained as described.5 Eighty-five environmental and
infant formula samples (using swabs and direct culturing of
fluids) were taken from incubators, humidifiers, antisep-
tics, soaps, and sinks, in an attempt to identify any possible
source of infection. Thirty-eight hand cultures were taken
from health care workers (HCWs) by a standard broth bag
technique.6 All the samples were incubated overnight in
brain heart infusion broth at 37C and subcultured on eosin
methylene blue agar. Additionally, two breast milk samples
were also taken from two mothers.
The isolates from clinical or screening specimens were
identified by standard laboratory methods, including the
Phoenix automatic system for the identification and suscep-
tibility testing (Becton Dickinson Bioscience). Antimicrobial
susceptibility tests were performed using the NMIC/ID-55
panels of the Phoenix automatic system, according to the
manufacturer’s instructions, and the results were inter-
preted according to the breakpoints established by the Clin-
ical and Laboratory Standards Institute.7 The antimicrobial
agents included were amoxicillin/clavulanate, ampicillin,
ampicillin/sulbactam, aztreonam, cefazolin, cefepime,
cefotaxime, ceftazidime, chloramphenicol, ciprofloxacin,
amikacin, gentamicin, imipenem, levofloxacin, meropenem,
piperacillin, piperacillin/tazobactam, tetracycline, and
trimethoprim/sulphamethoxazole. Extended spectrum beta-
lactamase (ESBL) production was initially screened by
Phoenix automatic system. ESBL production was also inves-
tigated by a double-disk test. The isolates were stored at
70C for further studies.
Pulsed-field gel electrophoresis typing
Molecular typing with pulse-field gel electrophoresis (PFGE)
was used to compare 13 S marcescens isolates, including
the samples from 10 patients, one hand wash sample, and
two breast milk samples. Of the 10 isolates, four were
derived from urine, three from blood, three from tracheal
aspirates, and one from an abscess. For PFGE analysis,
bacterial DNA was prepared as previously described with
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using 30 U per sample SpeI (Promega Corp., Madison, WI,
USA). Lambda phage concatemers (Bio-Rad Laboratories,
Richmond, CA, USA) were run simultaneously as a size
marker. The electrophoresis conditions using the CHEF-DR
III system (Bio-Rad) had an initial switch time of 5 seconds
and final switch time of 20 seconds (gradient of 6 V/cm and
an included angle of 120) for a 20-hour run. The gels were
stained for 20 minutes with ethidium bromide and
destained in distilled water for 45 minutes. The results
were analyzed with a Bio-Rad Gel Doc System (Bio-Rad) and
Molecular Analyst Software (Bio-Rad). The genotypes were
defined on the basis of DNA banding patterns as described
elsewehere.10 Isolates with identical patterns were
considered genetically “indistinguishable”, whereas those
that differed by one to three bands were defined as
“closely related”, four to six bands as “possibly related”,
and greater than or equal to seven bands as “unrelated”.
Results
The epidemiological data, antimicrobial profiles, and the
PFGE patterns, corresponding to all isolates, are summa-
rized in Tables 1 and 2. Environmental samples and hand
swabs from HCWs and breast milk samples from mothers
were obtained between April and June 2006 for S marcesces
isolation. Although no growth was obtained from 27 of the
environmental samples, there was one growth from the hand
samples of 14 HCWs and one from the milk samples taken
from the mothers of Patients 2 and 5 on April 4, 2006.
Additional hand cultures grew methicillin-resistant Staphy-
lococcus aureus, coagulase-negative staphylococci, Bacillus
spp., Escherichia coli, Enterobacter aerogenes, and Acine-
tobacter lwoffi. There was S marcesces growth in the milk
sample of Patient 5’s mother and in the urine sample taken
on the same day. No S marcesces growth was obtained from
any of the 17 environmental samples taken on May 30, 2006,
and 12 of the hand samples, including those hand samples
previously showing growth. Furthermore, there was no
growth of S marcesces in 41 of the environmental samples
and 14 of the HCW samples taken on June 3. In total, there
was one case of S marcesces growth from 38 hand samples
taken from HCWs and two of the breast milk samples taken











1 40 3,000 3/15/2006 3/21/2
2 33 2,300 3/24/2006 3/26/2
3 28 2,000 3/27/2006 3/27/2
4 40 3,250 3/19/2006 3/30/2
5 36 2,020 3/28/2006 4/1/20
6 34 3,100 4/8/2006 4/10/2
7 34 2,050 4/19/2006 4/21/2
8 38 3,860 5/1/2006 5/1/20
9 27 1,000 5/21/2006 5/22/2
10 22 630 5/20/2006 5/27/2the NICU; instead, mothers are called to provide breast milk
for their babies who are fed by nurses. For this reason,
breast milk was not available from other mothers. None of
the mothers had evidence of mastitis.
PFGE with SpeI yielded 16 or more visible bands for each
isolate. They were sufficiently distinct to allow the division
of the strains into three patterns (A, B, and C) with two
subtypes (A1and A2) (Fig. 1). Genomic typing identified one
major pattern, PFGE-designated Pattern A (Patients 1, 2, 4,
5, 8, and 10) shared by 6 of the 10 neonates, suggesting
some cross-transmission of this bacterial strain between
patients in the NICU. The PFGE patterns of isolates from
Patients 6 and 7 showed a one-fragment difference. Hence,
they were considered closely related (Pattern A1). The
isolates from the other two neonates were genetically
distinct. Two of the isolates from breast milk were indis-
tinguishable with PFGE Pattern A. The isolate obtained
from one hand-washing sample was unrelated to the
outbreak strain, which differed by seven bands (Pattern D).
With the exception of Clone D, all isolates belonging to
Clones A, A1, B, and C, were susceptible to trimethoprim/
sulfamethoxazole, amikacin, imipenem, meropenem, and
ciprofloxacin, whereas susceptibility to aztreonam, cefe-
pime, and piperacillin/tazobactam, varied among strains.
The Clone D strain was susceptible to cefotaxime, ceftazi-
dime, and gentamicin. No correlation was found between
PFGE and antibiotic patterns.
The outbreak was stopped by reinforcing standard
infection control procedures, including hand washing,
cohorting infected/colonized neonates, and disinfecting
environmental surfaces. No other infections by S marces-
cens were diagnosed, and the colonization rate returned to
the pre-epidemic value in another 12 months of follow-up
in the NICU.
Discussion
Serratia marcescens is a well-known causative agent of
hospital infections and can be the source of epidemic
outbreak in NICU.9 Recently, there have been several
reports of S marcescens outbreaks in NICUs3,9,11e15 where
the newborns known to be immature in the sense of proper
immune response are taken care of for various health
problems.11marcescens in neonatal intensive care unit
first isolation
d/yr)
Source of isolate Type of infection
006 Blood Septicemia
006 Urine Urinary tract infection
006 Blood Septicemia
006 Right wrist abscess Soft tissue infection
06 Urine Urinary tract infection
006 Urine Urinary tract infection
006 Tracheal aspirates Pneumonia
06 Urine Colonization
006 Tracheal aspirates Pneumonia
006 Blood Septicemia
Table 2 Phenotypic and genotypic characterization of Serratia marcescens isolates recovered from the neonatal intensive
care unit
_Isolate no. Source of isolate Antibiograma PFGE genotype
1 Blood (Neonate 1) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A
2 Urine (Neonate 2) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A
3 Blood (Neonate 3) Am, Azt, Cft, Caz, Pi, Gm, C, Cpe, Cfz B
4 Right wrist abscess (Neonate 4) Am, Azt, Cft, Caz, Pi, Gm, C, Cpe, Cfz A
5 Urine (Neonate 5) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A
6 Urine (Neonate 6) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cfz A1
7 Tracheal aspirates (Neonate 7) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A1
8 Urine (Neonate 8) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A
9 Tracheal aspirates (Neonate 9) Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz C
10 Blood (Neonate 10) Am, Cft, Caz, Pi, PTc Gm, C, Cpe, Cfz A
11 Hand of an HCW Am, Pi, PTc, Cfx, Cfz D
12 Breast milk for Neonate 2 Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A
13 Breast milk for Neonate 5 Am, Azt, Cft, Caz, Pi, PTc, Gm, C, Cpe, Cfz A
a Antibiograms are expressed as the antimicrobial resistance profiles.
AmZ ampicillin; AztZ aztreonam; CZ chloramphenicol; CazZ ceftazidime; CftZ cefotaxime; CfzZ cefazolin; CpeZ cefepime;
GmZ gentamicin; HCWZ health care worker; PiZ piperacillin; PTcZ piperacillin/tazobactam; PFGEZ pulsed-field gel electrophoresis.
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intravenous and topical solutions, or soap may seem to be
the pathogen’s source,12,16,17 whereas the hands of HCWs
can serve as an important source of infection.1 Colonization
rates of S marcescens on the hands of HCWs have been
described to range from 15.4% to 24%.17 However, it has been
reported that infected or colonized neonates are the primary
source in most S marcescens outbreaks.14 In our study,
environmental cultures from NICU were all negative for
S marcescens. Our intensive efforts failed to determine the
source of the outbreak despite the finding that S marcescens
strain was isolated from an HCW’s hand. The bacterial iso-
late obtained from the staff member was determined byFigure 1. Pulse-field gel electrophoresis (PFGE) of SpeI-
digested genomic DNA extracted from Serratia marcescens
isolates. Lanes 1 and 15 show molecular weight standards of
lambda in kilobase pairs. Lanes 2, 3, 5, 6, 9, 10, 13, and 14
show identical PFGE patterns responsible for the outbreak
(Pattern A) in Patients 1, 2, 4, 5, 8, and 10, and the breast milk
sample. Lanes 7 and 8 show the PFGE Pattern A1 from Patients
6 and 7, respectively. Lanes 4, 11, and 12 show distinct PFGE
patterns (B, C, and D) from Patients 3 and 9, and the hand
culture of a health care worker, respectively.PFGE to be unrelated to the outbreak strain, which differed
by seven bands. Despite our negative results, we believe
that cross-transmission through transient contamination of
hands played a major role in this outbreak. Because breast
milk has also been suggested to be a source of infection,18 we
also tested the breast milk samples of the mothers of
Patients 2 and 5 and detected S marcescens. The contami-
nated breast milk in our case could be implicated as a source
of infection in twoneonates, butwewere unable to conclude
definitely whether it is the case because no milk samples
could be taken from their mothers before the infection.
The PFGE patterns of isolates from Patients 3 and 9 were
genetically distinct from that of the outbreak-causing strain.
These neonates were transferred from another hospital to
our NICU, and infections occurred before or within 48 hours
of admission to our NICU, suggesting that they had acquired
the infection from the hospital where they were first
admitted.
Outbreaks of S marcescens have been reported to spread
very rapidly with significant morbidity and mortality.9,12,14
Therefore, the rapid typing methods are essential in terms
of prompt and sensitive evaluation of S marcescens outbreaks
in hospitals and, thus, implementing effective preventive
measures when the sources are identified.15 A number of
epidemiological typing methods, including antibiotyping,
serotyping, phage typing, plasmid typing, polymerase chain
reactionebased typing, and analysis of genomic DNA by PFGE
have been described. Antibiograms present little value in
most epidemiological studies because isolates with unrelated
genetic and epidemiological features have been shown to
present the same susceptibility pattern because of the
acquisition of the sameplasmid bymultiple species, named as
plasmid outbreak.19 In the present study, the antibiograms
revealed quite variable results as compared with those of
PFGE typing, and unrelated isolates had similar antibiotypes.
PFGE is the method of choice for outbreaks of S marces-
cens,3,12 and particularly, the method used in this study is
considerably rapid, taking about 28 hours to complete, to
allow prompt acting in the case of an outbreak and to
implement effective preventive measures.
Investigation of an outbreak of Serratia marcescens 115Although the source of the outbreak could not be defi-
nitely identified in the present study, it was concluded that
the successful growth of Smarcescens from the hand samples
of one HCW may indicate that transient contamination from
working staff may be more important than environmental
contamination. One of the interesting findings in our study
was to be able to grow S marcescens from a breast milk
sample, suggesting that contamination from mother’s milk
could be possible with a caveat that no correlation can be
established regarding contamination among patients. The
PFGE protocol used in this study is a simple, highly discrim-
inatory, and cost-effective method for the thorough epide-
miological investigation of an outbreak of S marcescens.
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